Single-Use Bioreactors-An Overview

Single-Use Technology in Biopharmaceutical Manufacture

Volumn , Issue , 2011, Pages 33-51

  Eibl, Regine ^a   Löffelholz, Christian ^a   Eibl, Dieter ^a  

^a ZURICH UNIVERSITY OF APPLIED SCIENCES   (Switzerland)

Author keywords

Disposable membrane bioreactors; Single use bioreactors; Stirred bioreactors; Stirred single use bioreactors; Wave mixed single use bioreactors

Indexed keywords

EID: 84861673533     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470909997.ch4     Document Type: Chapter

References (124)

1. Fenge C, Liillau E. (2006). Cell culture bioreactors. In SS Ozturk, WS Hu (eds.), Cell 4Culture Technology for Pharmaceutical and Cell-based Therapies. New York: CRC Press, pp. 155-224.
2. Marks DM. (2003). Equipment design considerations for large scale cell culture. Cytotechnology 42:21-33.
3. Henzler HJ. (2000). Particle stress in bioreactors. In K Schügerl, G Kretzmer (eds.), Influence of Stress on Cell Growth and Product formation. Series: Advances in Biochemical Engineering/Biotechnology, Vol. 67. Berlin; Heidelberg: Springer, pp. 38-82.
4. Nienow AW. (2006). Reactor engineering in large scale animal cell culture. Cytotechnolgy 50:9-33.
5. Eibl R, Eibl D. (2007). Disposable bioreactors for cell culturebased bioprocessing. ACHEMA Worldwide News 2:8-10.
6. Eibl R, Eibl D. (2007). Disposable bioreactors for inoculum production and protein expression. In R Pörtner (ed.), Animal Cell Biotechnology: Methods and Protocols, Series: Methods in Biotechnology, Vol. 24. Totowa, NJ: Humana Press, pp. 321-335.
7. Eibl R, Eibl D. (2009). Application of disposable bag bioreactors in tissue engineering and for the production of therapeutic proteins. In C Kasper, M van Griensven, R Pörtner (eds.), Bioreactor Systems for Tissue Engineering, Series: Advances in Biochemical Engineering/Biotechnology, Vol. 112. Berlin; Heidelberg: Springer, pp. 183-207.
8. Wilson JS. (2006). A fully disposable monoclonal antibody manufacturing train. BioProcess Int 4(Suppl. 4):34-36.
9. Genzel Y, Reichl U. (2007). Vaccine production: State of the art and future needs in upstream processing. In R Pörtner (ed.), Animal Cell Biotechnology: Methods and Protocols, Series: Methods in Biotechnology, Vol. 24. Totowa, NJ: Humana Press, pp. 457-473.
10. Scott C. (2008). Biotech leads a revolution in vaccine manufacturing. BioProcess Int 6(Suppl. 6): 12-18.
11. Harnis LS, Green C, Leshinsky N, Markham E, Miller K, Craig S. (2004). GMP production and testing of Xcellerated T cells for the treatment of patients with CLL. Cytotherapy 6:554-562.
12. GE Healthcare. (2008). Rapid production of clinical grade Tlymphocytes in the Wave Bioreactor. Available: http://www.5.gelifesciences.com/aptrix/upp0091.nsf./Content/F7AD616DACC22171C125747400812B51/file/28933149AA.pdf. Accessed August 15, 2009.
13. Negrete A, Kotin RM. (2008). Large-scale production of recombinant adeno-associated viral vectors. In JM Le Doux (ed.), Gene Therapy Protocols: Vol. I, Series: Methods in Molecular Biology, Vol. 433. Totowa, NJ: Humana Press, pp. 79-96.
14. Hsiao TY, Bacani FT, Carvalho EB, Curtis WR. (1999). Development of a low capital investment reactor system: Application for plant cell suspension culture. Biotechnol. Prog. 15:114-122.
15. Palazón J, Mallol A, Eibl R, Lettenbauer C, Cusido RM, Pinol MT. (2003). Growth and ginsenoside production in hairy root cultures of Panax ginseng using a novel bioreactor. Planta Med. 69:344-349.
16. Bentebibel S, Moyano E, Palazón J, Cusido RM, Bonfill M, Eibl R, Pinol MT. (2005). Effects of immobilization by entrapment in alginate and scale-up on paclitaxel and baccatin III production in cell suspension cultures of Taxus baccata. Biotechnol. Bioeng. 89:647-655.
17. Georgiev Ml, Weber J, Maciuk A. (2009). Bioprocessing of plant cell cultures for mass propagation of targeted compounds. Appl. Microbiol. Biotechnol. 83:809-823.
18. Eibl R, Werner S, Eibl D. (2009). Disposable bioreactors for plant liquid cultures at litre-scale. Eng. Life Sei. 9:156-164.
19. Eibl R, Werner S, Eibl D. (2009). Bag bioreactor based on wave-induced motion: Characteristics and applications. In D Eibl, R Eibl (eds.), Disposable Bioreactors, Series: Advances in Biochemical Engineering/Biotechnology, Vol. 115. Berlin; Heidelberg: Springer, pp. 55-87.
20. Mikola M, Seto J, Amanullah A. (2007). Evaluation of a novel Wave Bioreactor cellbag for aerobic yeast cultivation. Bioprocess BiosystEng. 30:231-241.
21. Eibl R, Eibl D. (2009). Disposable bioreactors in cell culturebased upstream processing. BioProcess Int 7(Suppl. I):18-23.
22. Falch FA, Heden CG. (1963). Disposable shaker flasks. Biotechnol. Bioeng. 5:211-220.
23. Knazek RA, Gullino PM, Kohler PO, Dedrick RL. (1972). Cell culture on artificial capillaries: An approach to tissue growth in vitro. Science 178:65-67.
24. Hopkinson J. (1985). Hollow fibre cell culture systems for economical cell-product manufacturing. BioTechno/ogy 3:225-230.
25. Gorter A, van de Griend RJ, van Eendenburg JD, Haasnot W H, Fleuren GJ. (1993). Production of bi-specific monoclonal antibodies in a hollow-fibre bioreactor./ Immunol. Methods 161:145-150.
26. Marx U. (1998). Membrane-based cell culture technologies: A scientifically economically satisfactory alternative malignant ascites production for monoclonal antibodies. Res. Immunol. 6:557-559.
27. Brecht R. (2009). Disposable bioreactors-Maturation into pharmaceutical glycoprotein manufacturing. In D Eibl, R Eibl (eds.), Disposable Bioreactors, Series: Advances in Biochemical Engineering/Biotechnology, Vol. 115. Berlin; Heidelberg: Springer, pp. 1-31.
28. Davis JM. (2007). Hollow fibre cell culture. In R Pörtner (ed.), Animal Cell Biotechnology: Methods and Protocols, Series Methods in Biotechnology, Vol. 24. Totowa, NJ: Humana Press, pp. 337-352.
29. Norris BJ, Gramer MJ, Hirschek MD. (2000). Growth of cell lines in bioreactors. In GC Howard, DR Bethell (eds.), Basic Methods in Antibody Production and Characterization. Boca Raton, FLCRC Press, pp. 87-104.
30. Davis JM. (2007). Systems for cell culture scale-up. In G Stacey, JM Davis (eds.), Medicines from Animal Cell Culture. Chichester, UK: John Wiley & Sons, pp. 145-171.
31. Schwander E, Rasmusen H. (2005). Scalable, controlled growth of adherent cells in a disposable, multilayer format. Genet Eng. Biotechnol. News 25:29.
32. DePalma A. (2002). Options for anchorage-dependent cell culture. Genet Eng. Biotechnol. News 22:58-62.
33. Bishop NE, Hugo DL, Borovec SV, Anderson DA. (1994). Rapid and efficient purification of hepatitis A virus from cell culture./Virol. Methods 47:203-216.
34. Nelson K, Bielicki J, Anson DS. (1997). Immobilization and characterization of a cell line exhibiting a severe multiple sulphatase deficiency phenotype. Biochem.J. 326:125-130.
35. Lee SY, Kim SH, Kim V N, Hwang JH, Jin M, Lee J, Kim S. (1999). Heterologous gene expression in avian cells: Potential as a producer of recombinant proteins./ Biomed. Sei. 6:8-17.
36. Hagen AJ, Aboud RA, DePhillips PA, Oliver CN, Orella CJ, Sitrin RD. (1996). Use of nuclease enzyme in the purification of VAQTA, a hepatits A vaccine. Biotechnol. Appl. Biochem. 23:209-215.
37. Ball P, Crawford B, Lindström K. (2009). 21st century vaccine manufacturing. BioProcess Int 4:18-28.
38. Beeksma LA, Kompier R. (1995). Cell growth and virus propagation in the Costar Cell Cube system. In EC Beuvery.JB Griffiths, WP Zeijlemaker (eds.), Animal Cell Technology: Developments towards the 21st Century. Dordrecht, The Netherlands: Kluwer, pp. 661-663.
39. Aunins JB, BibilaTA, Gatchalian S, Hunt GR, Junker BH, Lewis JA, Seifert DB, Licari P, Ramasubramanyan K, Ranucci CS, Seamans TC, Zhou W, Waterbury W, Buckland BC. (1997). Reactor development for the hepatitis A vaccine VAQTA. In MJT Carrondo, B Griffiths, JLP Moreira (eds.), Animal Cell Technology: From Vaccine to Genetic Medicine. Dordrecht, The Netherlands: Kluwer, pp. 175-183.
40. Ziv M, Ronen G, Ravlv M. (1998). Proliferation of meristematic clusters in disposable pre-sterilized plastic biocontainers for the large-scale propagation of plants. In Vitro Cell Dev. Bio/. Plant 34:152-158.
41. Ziv M. (1999). Organogenic plant regeneration in bioreactors. In A Altmann, M Ziv, S Izhar (eds.), Plant Biotechnology and In Vitro Biology in the 21st Century. Dordrecht, The Netherlands: Kluwer, pp. 673-676.
42. Ziv M. (2000). Bioreactor technology for plant micropropagation. Hort Rev. 24:1-30.
43. Ziv M. (2005). Simple bioreactors for mass propagation of plants. Plant Cell Tissue Organ Cult 81:277-285.
44. Curtis WR. (1999). Achieving economic feasibility for moderate-value food and flavour additives. In T Fu, G Singh, WR Curtis (eds.), Plant Cell and Tissue Culture for the Production of Food Ingredients. New York: Kluwer Academic, pp. 225- 236.
45. Curtis WR. (2004). Growing cells in a reservoir formed of a flexible sterile plastic liner. United States Patent 6709862B2.
46. Falkenberg FW. (1998). Production of monoclonal antibodies in the miniPerm bioreactor: Comparison with other hybridoma culture methods. Res. Immunol. 6:560-570.
47. McArdle J. (2004). Report of the workshop on monoclonal antibodies.ATM 32(Suppl. I):119-122.
48. Trebak M, Chong JM, Herlyn D, Speicher DW. (1999). Efficient laboratory-scale production of monoclonal antibodies using membrane-based high-density cell culture technology. J. Immunol. Methods 230:59-70.
49. Bruce MP, Boyd V, Duch C, White JR. (2002). Dialysisbased bioreactor systems for the production of monoclonal antibodies-Alternatives to ascites production in mice. J. Immunol. Methods 264:59-68.
50. Adam E, Sarrazin S, Landolfi C, Motte V, Lortat-Jacob H.Vassalle P, Delehedde M. (2008). Efficient long-term and high-yielded production of a recombinant proteoglycan in eukaryotic HEK293 cells using a membrane-based bioreactor. Biochem. Biophys. Res. Commun. 369:297-302.
51. Jain E, Kumar A. (2008). Upstream processes in antibody production: Evaluation of critical parameters. Biotechnol. Adv. 26:46-72.
52. McDonald KA, Hong LM.Trombly DM, Xie Q, Jackman AP. (2005). Production of human a-1-antitrypsin from transgenic rice cell culture in a membrane bioreactor. Biotechnol. Prog. 21:728-734.
53. Mitchell JP, Court J, Mason MD, Tabi Z, Clayton A. (2008). Increased exosome production from tumor cell cultures using the Integra CELLine culture system. Immunol. Methods 335:98-105.
54. Tamachi T, Maezawa Y, Ikeda K, Kagami S, Hatano M, Seto Y, Suto A, Suzuki K, Watanabe N, Saito Y.Tokihisa T, Iwamoto I, Nakajima H. (2006). IL-25 enhances allergic airway inflammation by amplifying aTH2-cell dependent pathway in mice. J. Allergy Clin. Immunol. I 18:606-614.
55. Willet BJ, McMonagle EL, Logan N, Samman A, Hosie MJ. (2008).A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction. Retrovirology 5:77-93.
56. Kybal J, Vlcek V. (1976).A simple device for stationary cultivation of microorganisms. Biotechnol. Bioeng. 18:1713-1718.
57. Kybal J, Sikyta B. (1985).A device for cultivation of plant and animal cells. Biotechnol. Lett. 7:467-47.
58. Singh V. (1999). Disposable bioreactor for cell culture using wave-induced motion. Cytotechno/ogy 30:149-158.
59. Lehmann J, Heidemann R, Riese U, Lütkemeyer D, Büntemeyer H. (1992). Der Superspinner-Ein "Brutschrankfermenter" für die Massenkultur tierischer Zellen. BioEngineering 5/6:112-117.
60. De Jesus MJ, Girard P, Bourgeois M, Baumgartner G, Kacko B, Amstutz H, Wurm FM. (2004). TubeSpin satellites: A fast track approach for process development with animal cells using shaking technology. Biochem. Eng.). 17:217-223.
61. Muller N, Girard P, Hacker D, Jordan M, Wurm FM. (2004). Orbital shaker technology for the cultivation of mammalian cells in suspension. Biotechnol. Bioeng. 89:400-406.
62. De Jesus MJ, Wurm FM. (2009). Medium and process optimization for high yield, high density suspension cultures: From low throughput spinner flasks to high throughput millilitre reactors. BioProcess Int 7(Suppl. I):12-17.
63. Zhang X, Biirki CA, Stettler M, De Sanctis D, Perrone M, Discacciati M, Parolini N, DeJesus M, Hacker DL, Quarteroni A, Wurm FM. (2009). Efficient oxygen transfer by surface aeration in shaken cylindrical containers for mammalian cell cultivation at volumetric scales up to 1000 L. Biochem. Eng.). 45:41-47.
64. Zhang X, Stettler M, De Sanctis D, Perrone M, Parolini N, Discacciati M, De Jesus M, Hacker D, Quarteroni A, Wurm F. (2009). Use of orbital shaken disposable bioreactors for mammalian cell cultures from the mL scale to the 1,000 L scale. In D Eibl, R Eibl (eds.), Disposable Bioreactors, Series: Advances in Biochemical Engineering/Biotechnology, Vol. 115. Berlin; Heidelberg: Springer, pp. 33-53.
65. Jia Q, Li H, Hui M, Hui N, Joudi A, Rishton G, Bao L, Shi M, Zhang X, Luanfeng L, Xu J, Leng G. (2008). A bioreactor system based on a novel oxygen transfer method. BioProcess Int 6:66-78.
66. Potera C. (2009). Firm on quest to improve biomanufacturing. Genet Eng. Biotechnol. News 7:20-21.
67. Werner S, Nägeli M. (2007). Good vibrations. B/oTechno/ogy 3:22-24.
68. Kauling J, Brod H, Schmidt S, Poggel M, Frahm B, Rose R. (2007). Einweg-Bioreaktor. Patent DE 102006018824AI.
69. Davis RM, Taylor G. (1950).The mechanics of large bubbles rising through liquids in tubes. Proc. R. Soc. Lond. A 200:375-392.
70. Nicklin DJ.Wilkes JO, Davidson JF. (1962).Two-phase flow in vertical tubes. Trans. Inst Chem. Engrs. 40:61-68.
71. Terrier B, Courtois C, Hénault N, Cuvier A, Bastin M, Aknin A, Dubreuil J, Pétiard V. (2007). Two new disposable bioreactors for plant cell cultures: The wave & undertow bioreactor and the slug bubble bioreactor. Biotechnol. Bioeng. 96:914-923.
72. Ducos JP, Terrier B, Courtois D, Pétiard V. (2008). Improvement of plastic-based disposable bioreactors for plant science needs. Phytochem. Rev. 7:607-613.
73. Ducos JP, Terrier B, Courtois D. (2009). Disposable bioreactors for plant micropropagation and cell cultures. In D Eibl, R Eibl (eds.), Disposable Bioreactors, Series: Advances in Biochemical Engineering/Biotechnology,Vol. 115. Berlin; Heidelberg: Springer, pp. 89-115.
74. Peacock L, Auton KA. (2008). Comparing shaker flasks with a single-use bioreactor for growing yeast seed cultures. BioProcess Int 6:54-57.
75. Heath C, Kiss R. (2007). Cell culture process development: Advances in process engineering. Biotechnol. Prog. 23:46-51.
76. Tutorial. (2005). High-yield single-use cell culture systems. Genet Eng. Biotechnol. News. Available: http:// www.genengnews.com/articles/chtitem.aspx?tid=l093&chid=3. Accessed August 22, 2009.
77. Drugmand JC, Havelange N, Debras F, Collignon F, Mathieu E, Castillo J. (2009). Human and animal vaccine production in a new disposable fixed-bed bioreactor. Available: http://www.artelis.be./uploads/pdf.POSTER%20ARTEFIX%20BD.pdf. Accessed August 22, 2009.
78. Glaser V. (2009). Bioreactor and fermentor trends. Genet eng. Biotechnol. News. Available: http://www.genengnews.com/issues/item.aspx. Accessed August 22, 2009.
79. Schreyer HB, Miller SE, Rodgers S. (2007). Application note: High-throughput process development. Genet Eng. biotecnnol News. Available: http://www.genengnews.com/issues.com/issues/item.aspx?issue_id=78. Accessed August 22, 2009.
80. Rao G, Moreira A, Brorson K. (2009). Disposable bioprocessing: The future has arrived. Biotechnol. Bioeng. 102:348-356.
81. Houtzager E, van der Linden R, de Roo G, Huurman S, Priem P, Sijmons PC. (2005). Linear scale-up of cell cultures. The next level in disposable bioreactor design. BioProcess Int 6:60-66.
82. Eibl R, Eibl D. (2006). Design and use of the Wave bioreactor for plant cell culture. In S Dutta Gupta, Y Ibaraki (eds.), Plant Tissue Culture Engineering, Series: Focus on Biotechnology, Vol. 6. Dordrecht,The Netherlands: Springer, pp. 203-227.
83. Knevelman C, Hearle DC, Osman JJ, Khan M, Dean M, Smith M, Aiyedebinu Cheung K. (2002). Characterization and operation of a disposable bioreactor as a replacement for conventional steam-in-place inoculum bioreactors for mammalian cell culture processes. Available: http://www.5.gelifesciences.com/aptrix/upp01077.nsf/Content/wave_bioreactor_home-wave_literature_WindowsInternetExplorer. Accessed August 23, 2009.
84. Hitchcock T. (2009). Production of recombinant whole-cell vaccines with disposable manufacturing systems. BioProcess Int 5:36-45.
85. D'Avino A, Zijlstra G, Oosterhuis N, van der Berg H. (2009). High cell density cultivation of PER.C6 cells in the CELL-tainer single-use bioreactor. Available: http://www.cellutionbiotech.com/Technology/Literature/image/ESACT-2009-PERC6-DSM. Accessed August 22, 2009.
86. Lonza. (2008). CELL-tainer single-use bioreactors. Walkersville, Brochure.
87. Paschedag AR. (2004). CFD in der Verfahrenstechnik. Weinheim: Wiley-VCH.
88. Menter FR. (1993). Zonal two equation k-cu turbulence models for aerodynamic flows. AIAA Paper:93-2906.
89. Öncül AA, Kalmbach A, Genzel Y, Reichl U, Thevenin D. (2009). Numerische und experimentelle Untersuchung der Fliessbedingungen in Wave-Bioreaktoren. CIT 81:1241.
90. Haidankar R, Li D, Saremi Z, Baikalov C, Deshpande R. (2006). Serum-free suspension large-scale transient transfection of CHO cells in Wave bioreactors. Mol. Biotechnol. 34:191-199.
91. Genzel Y, Behrendt I, Koenig S, Sann H, Reichl U. (2004). Metabolism of MDCK cells during cell growth and influence on virus production in large-scale microcarrier culture. Vaccine 22:2202-2208.
92. Genzel Y, Olmer RM, Schaefer B, Reichl U. (2006). Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media. Vaccine 24:6074-6087.
93. Rios M. (2006). Process considerations for cell-based influenza vaccines. Pharm. Technol. 4:1-6.
94. Slivac I, Srcek VG, Radosevic K, Kmetic I, Kniewald Z. (2006). Aujeszky's disease virus production in disposable bioreactors. J. Biosci. 3:363-368.
95. Hundt B, Best C, Schlawin N, Kassner H, Genzel Y, Reichl U. (2007). Establishment of a mink enteritis vaccine production process in stirred-tank reactor andWave®Bioreactor microcarrier cultures in I-10 L scale. Vaccine 25:3987-3995.
96. Hami LS, Chana H, Yuan V, Craig S. (2003). Comparison of a static process and a bioreactor-based process for the GMP manufacture of autologous Xcellerated T cells for clinical trials. BioProcessing J. 2:1-10.
97. Hami LS, Green C, Leshinsky N, Markham E, Miller K, Craig S. (2004). GMP production of Xcellerated T cells for the treatment of patients with CLL. Cytotherapy 6:554-562.
98. Levine B. (2007). Making waves in cell therapy: The Wave bioreactor for the generation of adherent and non-adherent cells for clinical use. Available: http://www.wavebiotech.com/pdf/ literature/ISCT_2007_Levine_Final.pdf. Accessed November 4, 2007.
99. Ritala A, Wahlström EH, Holkeri H, Hafren A, Mäkelamen K, Baez J, Mäkinen K, Nuutila AM. (2008). Production of a recombinant industrial protein using barley cell cultures. Protein Expr. Purif. 59:274-281.
100. Jablonski-Lorin C, Mellio V, Hungerbühler E. (2003). Stereoselective bioreduction to a chiral building block on a kilogram scale. Chimia 57:574-576.
101. Ries C. (2008). The process engineering characteristics of the Thermo Fisher Scientific Single-Use Bioreactor 50 L: Determination of mixing time, power input and kLa values. Application note. Available from Thermo Fisher Scientific.
102. Ozturk SS. (2007). Comparison of product quality: Disposable and stainless steel bioreactor. BioProduction 2007, Berlin, Germany.
103. Tollnik C. (2009). Einsatz von Disposables in der Praxis-ein Erfahrungsbericht zu Design und Betrieb einer Pilotanlage für klinische Wirkstoffproduktionen. 2. Konferenz Einsaß von Single-Use-Disposables (Concept Heidelberg). Mannheim, Germany.
104. Valentine P. (2009). Implementation of a single-use stirred bioreactor at pilot and GMP manufacturing scale for mammalian cell culture. ESACT 2009 Meeting, Dublin, Ireland.
105. Mardirosian D, Guertin P, Crowell J, Yetz-Aldape j, Hall M, Hodge G, Jonnalagadda K, Holmgren A, Galliher P. (2009). Scaling up a CHO-produced hormone-protein fusion product. BioProcess Int 7(Suppl. 4):30-35.
106. Galliher P. (2008). Achieving high-efficiency production with microbial technology in a single-use bioreactor platform. BioProcess Int I 1:60-65.
107. De Wilde D, Noack U, Kahlert W, Barbaroux M, Greller G. (2009). Bridging the gap from reusable to single-use manufacturing with stirred, single-use bioreactors. BioProcess Int 7(Suppl.4):36-4l.
108. Castillo J, Vanhamel S. (2007). Cultivating anchoragedependent cells. Genet Eng. Biotechnol. News 16:40-41.
109. Zambaux JP. (2007). How synergy answers the biotech industry needs. BioProduction 2007, Berlin, Germany.
110. Zambeaux JP, Vanhamel S, Bosco F, Castillo j. (2007). Disposable bioreactor. Patent EPI96I606A2.
111. Limke T. (2009). Comparability between the Mobius CellReady L bioreactor and 3 L glass bioreactors. BioProcess Int 7:122-123.
112. Maier U, Buchs J. (2001). Characterization of the gasliquid mass transfer in shaking bioreactors. Biochem. Eng. J. 7:99-106. 113
113. Gupta A, Rao G. 2003 A study of oxygen transfer in shake flasks using a non-invasive oxygen sensor. Biotechnol. Bioeng.84:351-358.
114. Maier U, Losen M, Buchs J. (2004). Advances in understanding and modeling the gas-liquid mass transfer in shake flasks. Biochem. Eng. J. 17:155-167.
115. Kato Y, Peter CP, Akgiin A, Buchs J. (2004). Power consumption and heat transfer resistance in large rotary shaking vessels. Biochem. Eng. J. 21:83-91.
116. Zhang H, Williams-Dalson W, Keshavarz-Moore E, Shamlou PA. (2005). Computational-fluid-dynamics (CFD) analysis of mixing and gas-liquid mass transfer in shake flasks. Biotechnol. Appl. Biochem. 41:1-8.
117. Wurm FM. (2007). Novel technologies for rapid and low cost provisioning of antibodies and process details in mammalian cell culture-based biomanufacturing. BioProduction 2007, Berlin, Germany.
118. Ries C, John C, Eib IR. (2009). Einwegbioreaktoren für die Prozessentwicklung mit Insektenzellen. Bioforum 3:11-13.
119. Liu CM, Hong LN. (2001). Development of a shaking bioreactor system for animal cell cultures. Biochem. Eng.J. 2:121- 125.
120. Raval K, Liu CM, Buchs J. (2006). Large-scale disposable shaking bioreactors. BioProcess Int 1:46-49.
121. Eib I.R, Kaiser S, Lombriser R, EibI D. (2010). Disposable bioreactors: The current state-of-the-art and recommended applications in biotechnology. Appl. Microbiol. Biotechnot. DOI: 10.1007/s002S3-009-2422-9.
122. Liu CZ.Towler MJ, Medrano G, Cramer CL, Weathers PJ. (2009). Production of mouse interleukin-12 is greater in tobacco hairy roots grown in a mist reactor than in an airlift reactor. Biotechnol. Bioeng. 102:1074-1086.
123. Weathers PJ, Towler MJ, X u J. (2010). Bench to batch: Advances in plant cell culture for producing useful products. Appl. Microbiol. Biotechnol. 85:1339-1351.
124. EibI D, EibI R (eds.). (2009). Disposable Bioreactors, Series: Advances in Biochemical Engineering/Biotechnology, Vol. I 15. Berlin; Heidelberg: Springer.